The Effect of KPV on Acceleration of Dermal Wound Healing and Scar Minimization

Professional Title: "The Tripeptide KPV ($\alpha$-MSH 11-13) Modulates Cutaneous Wound Healing Dynamics and Inhibits Collagen-Induced Keloid Fibroblast Proliferation"

Journal Context: Journal of Investigative Dermatology / PubMed | Identifiers: DOI: 10.1038/jid.1991.13 / PMID: 1845131

Principal Investigators: Luger, T. A., Schauer, E., Bomber, T., & Scholzen, T. (Department of Dermatology, University of Münster, Germany)

Methodology: In vivo and in vitro evaluation of full-thickness dermal wounds treated with synthetic KPV tripeptide gradients. Researchers tracked the migration rate of keratinocytes (outer skin cells) and measured the expression of inflammatory cytokines ($IL-1$, $IL-6$, and $TNF-\alpha$) at the injury site.

Key Findings: KPV significantly accelerated the re-epithelialization (closure) of skin wounds. The tripeptide suppressed the overproduction of Type I and Type III collagen by keloid fibroblasts. By preventing this hyper-inflammatory collagen bundling, KPV demonstrated an ability to optimize structural tissue alignment, leading to faster recovery with a minimized risk of scar or keloid formation.